Baldwin Calls on Republican Leaders to Bring Bipartisan Bill to Cap Insulin at $35 Up for a Vote
WASHINGTON, D.C. – Today, Senator Tammy Baldwin (D-WI) is calling on Majority Leader John Thune to bring the bipartisan legislation she co-sponsors to make insulin more accessible for millions of Americans to the Senate floor for a vote. The Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act caps the out-of-pocket cost of insulin at $35 per month, helping millions of Americans afford the medication they need. With 60 bipartisan co-sponsors, the bill has enough support to overcome a filibuster and pass the Senate.
“No one should have to go without the medication they need to stay healthy, and that includes the hundreds of thousands of Wisconsinites who rely on insulin every day. But as the rising cost of everything puts a strain on families’ budgets, too many of our neighbors are being forced to make hard choices between paying rent or putting food on the table and affording the sometimes lifesaving medications they need,” said Senator Baldwin. “The INSULIN Act would cap out-of-pocket costs for millions of Americans, saving them money and giving them one less thing to worry about each month — and I’m proud we have earned enough support from my Democratic and Republican colleagues to pass this bill. Now, it’s time for Majority Leader Thune to bring this up for a vote so we can deliver some much-needed relief to Wisconsinites.”
A report from the American Diabetes Association that shows the cost of diabetes in America, including the cost of insulin, continues to skyrocket for patients and the federal government. More than 40 million Americans live with diabetes, including over 526,000 Wisconsinites. The disease is one of the leading causes of death in the United States, claiming over 100,000 lives in 2021. It is also the most expensive chronic condition in the nation, costing Americans a combined total of $412.9 billion per year. The rising cost of insulin presents a barrier to care for a growing number of Americans living with diabetes; 1 in 4 individuals report reducing insulin use due to cost.
The INSULIN Act would directly address the root problems in the insulin market causing high list prices, while simultaneously extending vital patient protections, fostering competition, and broadening access to needed insulin products. More information about this bill is available here.
Senator Baldwin has long advocated for holding big drug companies accountable and expanding access to affordable health care for Wisconsinites. In 2022, she helped pass the Inflation Reduction Act, which for the first time allows Medicare to negotiate lower drug prices and caps the cost of insulin at $35-a-month for Medicare recipients. The INSULIN Act builds on that momentum to cap out-of-pocket costs for all Americans who rely on insulin.
NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
Senator Baldwin Urges Trump Admin to Imtely Address New World Screwworm Outbreak
Jun 15th, 2026 by U.S. Sen. Tammy BaldwinNew World screwworm has been confirmed in the U.S.
Baldwin, Khanna Lead Bill to Step Up Oversight on Foreign Investment to Protect American Workers, Prevent President’s Self-Dealing
Jun 11th, 2026 by U.S. Sen. Tammy BaldwinLegislation comes as White House boasts of trillions in foreign investments, including from China
